Clinical Trial Update: Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH [NA]

View source ↗

Summary

This clinical trial update indicates completion of a study characterizing immune semaphorin in non-alcoholic fatty liver disease and nonalcoholic steatohepatiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Non Alcoholic Fatty Liver Disease | NA | Status: COMPLETED